Claims
- 1. A triazolopyridine of the formula I ##STR56## where R.sup.1 is C.sub.1 -C.sub.20 -alkyl which can be interrupted by from 1 to 4 ether oxygen atoms, or is phenyl, mercapto or C.sub.1 -C.sub.20 -alkylthio,
- R.sup.3 is C.sub.1 -C.sub.4 -alkyl which may be interrupted by an ether oxygen atom, or is C.sub.1 -C.sub.4 -alkoxycarbonyl or phenyl,
- R.sup.4 is hydrogen, cyano, carbamoyl, carboxyl or C.sub.1 -C.sub.4 -alkoxycarbonyl and
- R.sup.5 is hydroxyl, mercapto, halogen, the radical --NL.sup.1 L.sup.2, where L.sup.1 and L.sup.2 are identical or different and independently of one another in each case are hydrogen or C.sub.1 -C.sub.4 -alkyl which may be interrupted by C.sub.1 -C.sub.4 -alkylimino, or the radical nitromethane, nitroethane or compounds of the formulae VII to VIII ##STR57## where X.sup.1 is cyano, nitro, C.sub.1 -C.sub.4 -alkanoyl, benzoyl which is unsubstituted or substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or halogen, C.sub.1 -C.sub.4 -alkylsulfonyl, or phenylsulfonyl, carboxyl, C.sub.1 -C.sub.4 -alkoxycarbonyl, phenoxycarbonyl, carbamoyl, C.sub.1 -C.sub.4 -monoalkylcarbamoyl or C.sub.1 -C.sub.4 -dialkylcarbamoyl, each of which is unsubstituted or substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or halogen, or phenylcarbamoyl which is unsubstituted or substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or halogen, or phenyl, each of which is unsubstituted or substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, halogen or nitro,
- X.sup.2 is C.sub.1 -C.sub.4 -alkyl or C.sub.1 -C.sub.4 -alkoxy,
- X.sup.3 is C.sub.1 -C.sub.4 -alkoxycarbonyl or phenylcarbamoyl.
- 2. The triazolopyridine of claim 1, wherein said C.sub.1 -C.sub.20 -alkyl radical is substituted with a substituent selected from the group consisting of phenyl, phenoxy, carboxyl or C.sub.1 -C.sub.20 -alkoxycarbonyl whose alkyl chain may be interrupted by from 1 to 4 ether oxygen atoms and may be substituted by phenyl or phenoxy.
- 3. The triazolopyridine of claim 1, wherein said phenyl radical is substituted with a substituent selected from the group consisting of C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, halogen, nitro or carboxyl.
- 4. A triazolopyridine as claimed in claim 1, wherein R.sup.4 is hydrogen.
- 5. A triazolopyridine as claimed in claim 1, wherein R.sup.3 is C.sub.1 -C.sub.4 -alkyl.
- 6. A triazolopyridine as claimed in claim 1, wherein R.sup.1 is C.sub.1 -C.sub.13 -alkyl or phenyl.
- 7. A triazolopyridine according to claim 1 of the formula: ##STR58##
- 8. A triazolopyridine according to claim 1 of the formula:
Priority Claims (1)
Number |
Date |
Country |
Kind |
43 26 758 |
Aug 1993 |
DEX |
|
Parent Case Info
This application is a Continuation of Ser. No. 08/592,311, filed on Feb. 12, 1996, abandoned, which is a 371 of International Application No. PCT/EP94/02233, filed on Jul. 7, 1994.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/EP94/02233 |
7/7/1994 |
|
|
2/12/1996 |
2/12/1996 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO95/04733 |
2/16/1995 |
|
|
Non-Patent Literature Citations (1)
Entry |
Geissler, et al., Preparation of substituted, etc CA 115:114513 1991 |
Continuations (2)
|
Number |
Date |
Country |
Parent |
592311 |
Feb 1996 |
|
Parent |
PCTEP9402233 |
Jul 1994 |
|